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Stylianos E. Antonarakis1,*It is a great honor, pleasure, and privilege to introduce to
themembers and guests of the American Society of Human
Genetics the recipient of the 2008 Allan Award, Haig H.
Kazazian Jr., who is currently the Saymour Gray Professor
of Molecular Medicine and Genetics and Chairman of
the Department of Genetics in the University of Pennsyl-
vania School of Medicine.
The list of Allan Awardees is tremendously distin-
guished; in all of them the Society recognizes ‘‘substantial
and far-reaching scientiﬁc contributions to human
genetics, carried out over a sustained period of scientiﬁc
inquiry and productivity.’’ Haig joins them with the pride
that his contributions were truly substantial, far-reaching,
important, unique, and many; in addition, Haig joins the
group with a unique style and charm.
Haig, a son of an Armenian couple of immigrants, was
born in Toledo Ohio. His father, from Kayseri, Turkey,
was lucky to escape the terror of the 1915 persecutions,
forced marches, concentration camps, and death (known
as the Armenian genocide); after many years of wandering,
he came to the U.S. in 1923. His mother came from Istan-
bul in 1920. Haig was raised with his brother in a house-
Stylianos E. AntonarakisThe Americhold in which Armenian, Turkish, and English were
spoken, that left an epigenetic mark on him that I recog-
nized many years later when I realized his kindness and
understanding towards people that spoke English with
a terrible accent, such as me. After his initial education in
the public school system, where he excelled in math and
chemistry, he attended Dartmouth College in Hannover,
NH, and received his A.B. in 1959; he continued with the
ﬁrst 2 years of Medical School there and then the 2 subse-
quent years at the Johns Hopkins University School of
Medicine in Baltimore, where he graduated in 1962. He
completed pediatrics training in the University of Minne-
sota Hospitals and at Hopkins and was attracted to a pedi-
atric genetics fellowship at Hopkins with Barton Childs
(1964–1966). During the Vietnam period, he was a Staff
Associate at the Laboratory of Molecular Biology of the
NIH, working with Harvey Itano. He joined the Faculty
of the Johns Hopkins University School of Medicine in
1969, rose quickly to Professor, and had a stellar Academic
career there for the next 25 years. At Hopkins he led the
pediatric genetics ﬁrst, and the Center forMedical Genetics
later, with special attention to excellence and to research
competitiveness. A considerable number of notable and
successful medical geneticists today consider Haig as their
mentor and a strong career supporter. He made numerous
important and exciting contributions to the under-
standing of the molecular basis of monogenic disorders,
particularly hemoglobinopathies and hemophilia. For
about a decade his laboratory was the most exciting place
for the study of the neutral and pathogenic genomic vari-
ability of the beta globin gene cluster; terms such as poly-
morphic sites, haplotypes, cross-over, linkage disequilib-
rium, and molecular detection were the daily routine
vocabulary. In addition, his laboratory was among the ﬁrst
in the world to establish a molecular detection facility for
monogenic disorders, and he was (with Dick Cotton) the
founding coeditor of the successful journal Human Muta-
tion. In the last 5 years of his Hopkins tenure, Haig became
interested in LINE retrotransposition, a theme that he
further developed as almost an exclusive subspecialty in
the genome analysis. In 1994, after a lot of thinking and
mixed feelings, he moved to the University of Pennsylva-
nia to chair the Department of Genetics. His research,
obsessively focused on the LINE elements now, blossomed
in spite of the numerous administrative responsibilities,
including building up the department and mentoring the1Professor and Chairman, Department of Genetic Medicine and Development, University of Geneva Medical School and University Hospitals of Geneva,
1 rue Michel-Servet, 1211 Geneva, Switzerland
*Correspondence: Stylianos.Antonarakis@unige.ch
DOI 10.1016/j.ajhg.2009.01.002. ª2009 by The American Society of Human Genetics. All rights reserved.an Journal of Human Genetics 84, 103–104, February 13, 2009 103
young faculty members. Most of us who admire Haig’s
achievements wonder how he was and is able to manage
his time in such a way that he stays in the forefront of
research and maintains a well-funded laboratory in the
midst of academic detractions and the time-eater adminis-
trative burden. His scientiﬁc journey has produced more
that 350 well-cited papers, some of them classics1–11 by
now, and avant garde at the time of publication. For his
contributions Haig has been honored by theMead Johnson
Award for Pediatric Research, an award from the National
Hemophilia Foundation, the Institute of Medicine of the
National Academy of Sciences, which elected him as a
member, and the American Academy of Arts and Sciences.
More than 50 postdocs and graduate students had the
privilege and the good luck to work in his scientiﬁc envi-
ronment. I was very lucky and honored to be one of
them. With an MD degree from the University of Athens,
a couple of years of clinical residency, a lot of dreams, and
the vivid image of the Acropolis view when I opened my
window at home, I arrived in Baltimore a humid and
100F hot summer day; I put my suitcase in the thenmiser-
able Reed Hall across the dome and went directly to the
lab at CMSC10. I found Haig sitting in the middle of
the lab talking to people around him as they were pipetting
or loading a gel or looking at bands on a ﬁlm. He
was a warm, unpretentious, civilized, curious, talkative
gentleman, with a burning internal ﬁre for conquering
the unknown. Fifteen minutes of conversation and the
fact that he was there in the middle of the lab all the time
convinced me that his lab was what I was looking for and
in my dreams was comparable to that of the Morgan lab
at Columbia that I had read before extensively. In the
next almost 15 years, he walked me through the wonders
of the lab work, helped me to dream of restriction sites,
and showed me the way to become an independent inves-
tigator, a fair competitor, a collaborator, and a friend.
Haig is also an exemplary family man, proud for his
blessed life with Lilli, and also proud for his children
Haig and Sonya, their families, and his ﬁve grandchildren.
Haig is quite an overachiever. His contributions are often
appreciated after the dust is settled, and unlike with other
cases, time shows how important what he did was. He is
a true gentleman, who avoids conﬂict and quietly and
continuously (r)evolutionizes his ﬁeld. The people
who know him well say that his three most prominent
characteristics are (1) his great scientiﬁc intellect and his
uncompromising approach to the generation of high-
quality results; (2) his generosity in supporting the careers104 The American Journal of Human Genetics 84, 103–104, Februaryof those under him, even long after he has any direct
responsibility for doing so; and (3) his modesty (and this
is part of the reason why his work perhaps has not received
the recognition it deserves).
It is with great personal pleasure, appreciation, and
respect that I present to the members of the American
Society of Human Genetics Dr. Haig H. Kazazian, Jr. as
the recipient of the 2008 William Allan Award.
References
1. Kazazian, H.H., Jr., Young, W.J., and Childs, B. (1965). X-
linked 6-phosphogluconate dehydrogenase in drosophila:
subunit associations. Science 150, 1601–1602.
2. Phillips, J.A. 3rd, Snyder, P.G., and Kazazian, H.H., Jr. (1977).
Ratios of alpha-to beta-globin mRNA and regulation of globin
synthesis in reticulocytes. Nature 269, 442–445.
3. Antonarakis, S.E., Boehm, C.D., Giardina, P.J., and Kazazian,
H.H., Jr. (1982). Nonrandom association of polymorphic
restriction sites in the beta-globin gene cluster. Proc. Natl.
Acad. Sci. USA 79, 137–141.
4. Orkin, S.H., Kazazian, H.H. Jr., Antonarakis, S.E., Goff, S.C.,
Boehm, C.D., Sexton, J.P., Waber, P.G., and Giardina, P.J.
(1982). Linkage of beta-thalassaemia mutations and beta-
globin gene polymorphisms with DNA polymorphisms in
human beta-globin gene cluster. Nature 296, 627–631.
5. Chakravarti, A., Buetow, K.H., Antonarakis, S.E., Waber, P.G.,
Boehm, C.D., and Kazazian, H.H. (1984). Nonuniform recom-
bination within the human beta-globin gene cluster. Am.
J. Hum. Genet. 36, 1239–1258.
6. Kazazian, H.H., Jr., Wong, C., Youssouﬁan, H., Scott, A.F., Phil-
lips, D.G., and Antonarakis, S.E. (1988). Haemophilia A result-
ing from de novo insertion of L1 sequences represents a novel
mechanism for mutation in man. Nature 332, 164–166.
7. Dombroski, B.A., Mathias, S.L., Nanthakumar, E., Scott, A.F.,
and Kazazian, H.H., Jr. (1991). Isolation of an active human
transposable element. Science 254, 1805–1808.
8. Bi, L., Lawler, A.M., Antonarakis, S.E., High, K.A., Gearhart,
J.D., and Kazazian, H.H., Jr. (1995). Targeted disruption of
the mouse factor VIII gene produces a model of haemophilia
A. Nat. Genet. 10, 119–121.
9. Moran, J.V., Holmes, S.E., Naas, T.P., DeBerardinis, R.J., Boeke,
J.D., and Kazazian, H.H., Jr. (1996). High frequency retrotrans-
position in cultured mammalian cells. Cell 87, 917–927.
10. Moran, J.V., DeBerardinis, R.J., and Kazazian, H.H., Jr. (1999).
Exon shufﬂing by L1 retrotransposition. Science 283, 1530–
1534.
11. Ostertag, E.M., DeBerardinis, R.J., Goodier, J.L., Zhang, Y.,
Yang, N., Gerton, G.L., and Kazazian, H.H., Jr. (2002). Amouse
model of human L1 retrotransposition. Nat. Genet. 32,
655–660.13, 2009
